ORINY Projected Dividend Yield
ADR/Orion Corp (New) (Finaland) ( OTCBB : ORINY )Orion and its subsidiaries develop and manufacture pharmaceuticals, active pharmaceutical ingredients and diagnostic tests that are marketed globally. Co. and its subsidiaries have two segments: Pharmaceuticals and Diagnostics. The Pharmaceuticals business develops, manufactures and markets pharmaceuticals and active pharmaceutical ingredients. The Pharmaceuticals business portfolio includes Co.'s Stalevo® (carbidopa, levodopa and entacapone) and Comtess®/Comtan® (entacapone) Parkinson's drugs. The Diagnostics business develops, manufactures and markets diagnostic tests. 18 YEAR PERFORMANCE RESULTS |
ORINY Dividend History Detail ORINY Dividend News ORINY Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
2024 |
N/A |
Oct 16, 2024 |
Oct 16, 2024 |
Nov 07, 2024 |
0.2405 |
2024 |
N/A |
Mar 21, 2024 |
Mar 22, 2024 |
Apr 18, 2024 |
0.4375 |
2024 Total: |
0.6780 |
||||
2023 |
N/A |
Mar 23, 2023 |
Mar 24, 2023 |
Apr 17, 2023 |
0.8699 |
2023 Total: |
0.8699 |
||||
2022 |
N/A |
Mar 24, 2022 |
Mar 25, 2022 |
Apr 18, 2022 |
0.8282 |
2022 Total: |
0.8282 |
||||
2021 |
N/A |
Mar 26, 2021 |
Mar 29, 2021 |
Apr 22, 2021 |
0.8902 |
2021 Total: |
0.8902 |
||||
2020 |
N/A |
May 07, 2020 |
May 08, 2020 |
Jun 01, 2020 |
0.8098 |
2020 Total: |
0.8098 |
||||
2019 |
N/A |
Mar 27, 2019 |
Mar 28, 2019 |
Apr 19, 2019 |
0.8405 |
2019 Total: |
0.8405 |